Endothelin-converting enzyme expression in the neointima after percutaneous coronary intervention

Area of Science:

• Cardiovascular Biology
• Vascular Biology
• Cellular Biology

Background:

• Smooth muscle cells (SMCs) are key components of neointimal tissue following percutaneous coronary intervention (PCI).
• Endothelin-1 (ET-1), a potent vasoconstrictor and mitogen for SMCs, is generated via endothelin-converting enzyme (ECE).
• The role of ECE in post-PCI vascular repair remains uncharacterized.

Purpose of the Study:

• To investigate the expression and localization of ECE in neointimal tissues after PCI.
• To determine the association of ECE expression with SMCs in the context of vascular repair post-PCI.

Main Methods:

• Analysis of human coronary artery samples (autopsy and atherectomy) from patients who underwent PCI.
• Immunohistochemical staining for ECE, SMCs, macrophages, and endothelial cells.
• Quantitative assessment of ECE immunoreactivity using computer-aided planimetry.

Main Results:

• ECE expression was detected in neointimal SMCs at early stages post-PCI.
• ECE-positive cell area was significantly higher in samples within 3 months post-PCI compared to those from 6 months onward.
• Atherectomy specimens from restenotic sites also demonstrated significant ECE positivity in neointimal SMCs.

Conclusions:

• Endothelin-converting enzyme (ECE) is upregulated in the neointima during the early phase of vascular repair after PCI.
• ECE may function as a mediator in the cellular processes contributing to neointimal hyperplasia following PCI.
• These findings highlight ECE as a potential target for therapeutic intervention in post-PCI vascular remodeling.